Jing Han

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Venues

Journal of medicinal chemistry

ACS applied bio materials

Molecular pharmaceutics

RSC advances

Jiangsu Normal University

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jiangsu Normal University Feb 15 2014

China

Assitant Professor

Education History

China Pharmaceutical University Sep 01 2008 - Jun 30 2013

China

PHD

Publications

Neng Jiang, Di Su, De Chen, Shutong Huang, Chunli Tang, Lin Jing, Caiyan Yang, Zhongbo Zhou, Zhiming Yan, Jing Han
Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists. Journal of medicinal chemistry 67 (1) (2023)
Lu-Lu Qu, Jing Han, Yi Huang, Guo-Hai Yang, Weijie Liu, Zhouyang Long, Yingqiu Gu, Qingming Zhang, Ming Gao, Xiaochen Dong
Peroxidase-like Nanozymes for Point-of-Care SERS Sensing and Wound Healing. ACS applied bio materials 6 (3) (2023)
Neng Jiang, Di Su, De Chen, Shutong Huang, Chunli Tang, Lin Jing, Caiyan Yang, Zhongbo Zhou, Zhiming Yan, Jing Han
Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists. Journal of medicinal chemistry (2023)
Lu-Lu Qu, Jing Han, Yi Huang, Guo-Hai Yang, Weijie Liu, Zhouyang Long, Yingqiu Gu, Qingming Zhang, Ming Gao, Xiaochen Dong
Peroxidase-like Nanozymes for Point-of-Care SERS Sensing and Wound Healing. ACS applied bio materials 6 (3) (2023)
Neng Jiang, Di Su, De Chen, Shutong Huang, Chunli Tang, Lin Jing, Caiyan Yang, Zhongbo Zhou, Zhiming Yan, Jing Han
Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists. Journal of medicinal chemistry 67 (1) (2023)
Lu-Lu Qu, Jing Han, Yi Huang, Guo-Hai Yang, Weijie Liu, Zhouyang Long, Yingqiu Gu, Qingming Zhang, Ming Gao, Xiaochen Dong
Peroxidase-like Nanozymes for Point-of-Care SERS Sensing and Wound Healing. ACS applied bio materials (2023)
Neng Jiang, Di Su, De Chen, Shutong Huang, Chunli Tang, Lin Jing, Caiyan Yang, Zhongbo Zhou, Zhiming Yan, Jing Han
Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists. Journal of medicinal chemistry 67 (1) (2023)
Songfeng Zhao, Zhiming Yan, Yue Du, Zeyun Li, Chunli Tang, Lin Jing, Lidan Sun, Qimeng Yang, Xueling Tang, Yongliang Yuan, Jing Han, Neng Jiang
A GLP-1/glucagon (GCG)/CCK 2 receptors tri-agonist provides new therapy for obesity and diabetes. British journal of pharmacology 179 (17) (2022)
Qimeng Yang, Weizhong Tang, Lidan Sun, Zhiming Yan, Chunli Tang, Yongliang Yuan, Huan Zhou, Feng Zhou, Siyuan Zhou, Qingqing Wu, Peng Song, Ting Fang, Ronglian Xu, Jing Han, Neng Jiang
Design of Xenopus GLP-1-Based Long-Acting Dual GLP-1/Y 2 Receptor Agonists. Journal of medicinal chemistry 65 (20) (2022)
Chun Han, Yuqing Sun, Qimeng Yang, Feng Zhou, Xinyu Chen, Lintao Wu, Lidan Sun, Jing Han
Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease. Molecular pharmaceutics 18 (8) (2021)
Chunli Tang, Qing Li, Xiaoyan Deng, Weiwei Wu, Liufeng Liao, Kai Liang, Rongrui Huo, Chenglin Li, Jing Han, Weizhong Tang, Neng Jiang
Discovery of lixisenatide analogues as long-acting hypoglycemic agents using novel peptide half-life extension technology based on mycophenolic acid. RSC advances 10 (20) (2020)
Shuang Zhao, Peng Zhang, Zhangjian Zou, Jing Han, Weihua Yang, Qianshu Sun
Polysaccharides derived from Enteromorpha prolifera for the removal of silver nanoparticle-humic acid contaminants by a coagulation-ultrafiltration process. RSC advances 10 (27) (2020)
Xinyu Chen, Junjie Fu, Feng Zhou, Qimeng Yang, Jialing Wang, Hui Feng, Wen Jiang, Luofan Jin, Xuelin Tang, Neng Jiang, Jian Yin, Jing Han
Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes. Journal of medicinal chemistry 63 (21) (2020)
Junjie Fu, Jing Han, Tingting Meng, Jing Hu, Jian Yin
Novel α-ketoamide based diazeniumdiolates as hydrogen peroxide responsive nitric oxide donors with anti-lung cancer activity. Chemical communications (Cambridge, England) 55 (86) (2019)
Lidan Sun, Jing Han, Xinyu Chen, Yue Han, Lingling Wu, Xia E
Novel mono-lipidated dimeric glucagon-like peptide-1 receptor agonist with improved long-acting and hypoglycemic activity. RSC advances 9 (17) (2019)
Tingting Meng, Jing Han, Pengfei Zhang, Jing Hu, Junjie Fu, Jian Yin
Introduction of the α-ketoamide structure: en route to develop hydrogen peroxide responsive prodrugs. Chemical science 10 (30) (2019)
Jing Han, Yingying Fei, Feng Zhou, Xinyu Chen, Ying Zhang, Lin Liu, Junjie Fu
Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities. British journal of pharmacology 175 (3) (2018)
Jing Han, Feng Zhou, Yingying Fei, Xinyu Chen, Junjie Fu, Hai Qian
Preparation and Pharmaceutical Characterizations of Lipidated Dimeric Xenopus Glucagon-Like Peptide-1 Conjugates. Bioconjugate chemistry 29 (2) (2018)
Jing Han, Xinyu Chen, Li-Ming Zhao, Junjie Fu, Lidan Sun, Ying Zhang, Feng Zhou, Yingying Fei
Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs. Molecular pharmaceutics 15 (7) (2018)
Jing Han, Junjie Fu, Lidan Sun, Yue Han, Qiuyi Mao, Fang Liao, Xinshi Zheng, Ke Zhu
Synthesis and pharmaceutical characterization of site specific mycophenolic acid-modified Xenopus glucagon-like peptide-1 analogs. MedChemComm 9 (1) (2017)
Jing Han, Yingying Fei, Feng Zhou, Xinyu Chen, Weiwei Zheng, Junjie Fu
Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes. Molecular pharmaceutics 14 (11) (2017)

Jing Han.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jing Han